Similar Items: Aggressive Natural Killer Cell Leukemia: A Rare and Rapidly Progressive Hematologic Malignancy—Case Report and Literature Review
- Prevalence, Risk Factors, and Prognostic Impact of Spontaneous Tumor Lysis Syndrome in Aggressive Hematologic Malignancies: Experience From the Clinical Hematology Department, University of Dakar
- Bispecific Antibodies in Hematologic Malignancies in the Outpatient and Community Settings
- Malignancy-Associated Hemophagocytic Lymphohistiocytosis: An Experience of 15 Years in Polish Pediatric Hematology Centers
- IGF2BP3 inhibition: another home run for RNA-binding protein targeting in hematological malignancies
- Hematological Biomarkers in Predicting Progression and Complications of Chronic Kidney Disease Among Adult Patients
- The Incidence of Hemolytic and Serologic Transfusion Reactions Among Patients with Hematological Malignancies at Mbarara Regional Referral Hospital and the Uganda Cancer Institute, in Uganda